NuVasive has been in the news this week after it was reported that Smith & Nephew was interested in acquiring the company for more than $3 billion. Neither company has officially commented on the rumored deal.
After spending 2018 dealing with quality control remediation and supply chain issues, Zimmer Biomet expects to return to market growth by 2020.
As Zimmer Biomet prepares to enter a surging robotics market, CEO Bryan Hanson said the company wants to make sure the company does it right.
Stryker reported strong performance in the fourth quarter of 2018 with a record number of robots installed and a healthy order book going into 2019.
A $100M joint venture is expected to improve access to advanced rehabilitation technologies for Chinese stroke and spinal cord injury patients.
Co-developed by Medtronic and the recently acquired Mazor Robotics, the system represents a unique marriage between robotics and navigation.
The Warsaw, IN-based company has received clearance for the ROSA Knee System to be used in robotically-assisted total knee replacement procedures.
University of Bristol Medical School Researchers led a study that shows cemented metal-on-plastic hip replacements less than 36 mm in diameter are the most cost-effective in patients older than 65.
Zimmer Biomet is expected to launch a robot soon that will compete with Stryker's Mako Total Knee offering.
Zimmer Biomet CEO Bryan Hanson says the company must start reducing the size of its portfolio in order to simplify the supply chain and improve service levels to customers.
The Yokneam, Israel based company has the distinction of being one of the first companies to receive a nod from FDA for its exoskeleton technology.
Zimmer will partner with Apple to study the mymobility app’s impact on patient outcomes and overall costs for joint replacement patients.
Exploring the current state of robotic-assisted surgery and what to expect from future surgical robots.
Medtronic's new Infinity OCT system aligns navigation with biologics and devices for a more efficient spinal fusion procedure.
More than two years after Medtronic first hitched its wagon to Mazor Robotics, the pair is making it official through an acquisition valued at $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired.